DexCom, Inc. Equity-NMS: DXCM

Healthcare

Medical Devices

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$88.27
Open :	$87.52
Today's high :	$88.02
Today's low :	$86.65
52W low :	$62.34
52W high :	$142
1Y :	-26.62%
5Y :	41.1%
EPS(TTM): :	1.65
Shares O/S :	390.6 M
Market cap :	39.06 B

What is the share price of DexCom, Inc. today?

DexCom, Inc. (DXCM) share price as of February 10, 2025, is $88.27. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of DexCom, Inc.?

Yes, Indian Investors can invest in the DexCom, Inc. (DXCM) Share by opening an international trading account with Angel One.

How can I purchase DexCom, Inc. shares in India?

Purchasing DexCom, Inc. (DXCM) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying DexCom, Inc. (DXCM) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of DexCom, Inc.?

Yes, you can purchase fractional shares of DexCom, Inc. (DXCM) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of DexCom, Inc.?

The market capitalization of DexCom, Inc. on February 10, 2025, is $39.06 B.

In which sector DexCom, Inc. belongs?

DexCom, Inc. operates in the Healthcare sector, specifically in the Medical Devices industry.

What documents are required to invest in DexCom, Inc. stocks?

In order to invest in DexCom, Inc. (DXCM) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

DexCom, Inc. is a medical device company. The Company enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The Company is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The Company is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Dexcom Stelo is designed specifically for people with type II diabetes who do not use insulin and are not at risk for hypoglycemia. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device.